Marcello Arca

Pubblicazioni

Titolo Pubblicato in Anno
Lipoprotein (a): a genetic marker for cardiovascular disease and target for emerging therapies JOURNAL OF CARDIOVASCULAR MEDICINE 2020
Efficacy and Safety of Volanesorsen (ISIS 304801): the Evidence from Phase 2 and 3 Clinical Trials CURRENT ATHEROSCLEROSIS REPORTS 2020
Evaluation of efficacy and safety of antisense inhibition of apolipoprotein C-III with volanesorsen in patients with severe hypertriglyceridemia EXPERT OPINION ON PHARMACOTHERAPY 2020
Current lipid lowering treatment and attainment of LDL targets recommended by ESC/EAS guidelines in very high-risk patients with established atherosclerotic cardiovascular disease: Insights from the START registry INTERNATIONAL JOURNAL OF CARDIOLOGY 2020
Homozygous familial hypercholesterolemia in Italy: Clinical and molecular features ATHEROSCLEROSIS 2020
ApoCIII: A multifaceted protein in cardiometabolic disease METABOLISM, CLINICAL AND EXPERIMENTAL 2020
Familial combined hypolipidemia: Angiopoietin-like protein-3 deficiency CURRENT OPINION IN LIPIDOLOGY 2020
Autosomal recessive hypercholesterolemia: update for 2020 CURRENT OPINION IN LIPIDOLOGY 2020
How registers could enhance knowledge and characterization of genetic dyslipidaemias: The experience of the LIPIGEN in Italy and of other networks for familial hypercholesterolemia ATHEROSCLEROSIS SUPPLEMENTS 2020
High TG to HDL ratio plays a significant role on atherosclerosis extension in prediabetes and newly diagnosed type 2 diabetes subjects DIABETES/METABOLISM RESEARCH AND REVIEWS 2020
Metabolomic Signature of Angiopoietin-Like Protein 3 Deficiency in Fasting and Postprandial State ARTERIOSCLEROSIS, THROMBOSIS, AND VASCULAR BIOLOGY 2019
Genetic and metabolic predictors of hepatic fat content in a cohort of Italian children with obesity PEDIATRIC RESEARCH 2019
A novel splicing mutation in the ABCA1 gene, causing Tangier disease and familial HDL deficiency in a large family BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 2019
Lysosomal acid lipase activity and liver fibrosis in the clinical continuum of non-alcoholic fatty liver disease LIVER INTERNATIONAL 2019
Variation of PEAR1 DNA methylation influences platelet and leukocyte function. CLINICAL EPIGENETICS 2019
Spectrum of mutations and long-term clinical outcomes in genetic chylomicronemia syndromes ARTERIOSCLEROSIS, THROMBOSIS, AND VASCULAR BIOLOGY 2019
Rare dyslipidaemias, from phenotype to genotype to management: a European Atherosclerosis Society Task Force Consensus Statement THE LANCET DIABETES & ENDOCRINOLOGY 2019
Nonalcoholic Fatty Liver Disease (NAFLD), But not Its Susceptibility Gene Variants, Influences the Decrease of Kidney Function in Overweight/Obese Children INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2019
Volanesorsen and Triglyceride Levels in Familial Chylomicronemia Syndrome NEW ENGLAND JOURNAL OF MEDICINE 2019
ZBTB12 DNA methylation is associated with coagulation- and inflammation-related blood cell parameters: Findings from the Moli-family cohort CLINICAL EPIGENETICS 2019

Progetti di Ricerca

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma